Dr. Scott Anthony Brancolini, MD, MPH

Dr. Brancolini practices at UPMC St. Margaret in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Brancolini's NPI, 1700090768, was assigned on May 9, 2007. Dr. Brancolini graduated from Pennsylvania State University College of Medicine in 2002. Dr. Brancolini holds Pennsylvania license MD429152.

Dr. Brancolini's primary practice is UPMC St. Margaret, at 815 Freeport Road, Pittsburgh, PA 15215 in Allegheny County. The practice phone is (412) 784-4000.

Dr. Brancolini's primary practice is UPMC St. Margaret in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Brancolini is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Brancolini to 4 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brancolini practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Brancolini's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Brancolini is licensed in Pennsylvania.

CMS data shows 521 Medicare services from Dr. Brancolini across 7 procedure codes in 2024, for 178 Medicare patients. Medicare paid $30,949 for them.

CMS counts 178 Medicare patients who saw Dr. Brancolini in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have arthritis, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brancolini's median patient age at 71, with 66% women.

In 2024, Dr. Brancolini wrote 1,922 Medicare Part D claims for 326 patients. 96% of them were for generic drugs. CMS names the drug for 1,854 of them, across 22 drugs with 11 or more claims each, at $68,313 in total drug cost. In 2023, CMS named 1,757 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Brancolini for performance year 2024, reported as part of a group. Dr. Brancolini accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brancolini as offering telehealth.

Dmand AI links 18 papers to Dr. Brancolini, published from 2019 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Pain, Analgesics and COVID-19. Dr. Brancolini has published most often in Pain Med. Dr. Brancolini's most frequent co-authors are Trent David Emerick, MD, Benedict Joseph Alter, MD, PhD and Lynn R. Kohan, MD.

CMS Open Payments shows 79 general payments to Dr. Brancolini from 12 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 93% of the total. Abbott Laboratories paid the most, $5,500.

Dr. Brancolini graduated from Pennsylvania State University College of Medicine in 2002.